REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio Eel SRL (Romania)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bio Eel SRL Profile Updated: November 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bioeel is a pharmaceutical company that specializes in the development and production of medical treatments, including Sildenafil and Tramadol tablets. They are certified for compliance with good manufacturing practices and focus on promoting a responsible, health-oriented lifestyle.

Headquarters
Strada Bega Nr. 5
TARGU MURES; Mures; Postal Code: 540390

Contact Details: Purchase the Bio Eel SRL report to view the information.

Website: http://www.bioeel.ro

Basic Information
Total Employees:
Purchase the Bio Eel SRL report to view the information.
Outstanding Shares:
Purchase the Bio Eel SRL report to view the information.
Registered Capital:
Purchase the Bio Eel SRL report to view the information.
Financial Auditors:
Purchase the Bio Eel SRL report to view the information.
Incorporation Date:
June 18, 1992
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bio Eel SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
33.61%
Total operating revenue
33.32%
Operating profit (EBIT)
57.25%
EBITDA
54.76%
Net Profit (Loss) for the Period
48.45%
Total assets
40.41%
Total equity
12.95%
Operating Profit Margin (ROS)
0.3%
Net Profit Margin
0.15%
Return on Equity (ROE)
4.43%
Debt to Equity Ratio
17.82%
Quick Ratio
-0.07%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?